{"id":62330,"title":"Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.","abstract":"","date":"2014-05-09","categories":"Hemic and Lymphatic Diseases","split":"train","url":"http://www.ncbi.nlm.nih.gov/pubmed/24591201","annotations":[{"name":"Randomized controlled trial","weight":0.216279,"wikipedia_article":"http://en.wikipedia.org/wiki/Randomized_controlled_trial"},{"name":"National Hockey League","weight":0.0393397,"wikipedia_article":"http://en.wikipedia.org/wiki/National_Hockey_League"},{"name":"Medial collateral ligament","weight":0.0297972,"wikipedia_article":"http://en.wikipedia.org/wiki/Medial_collateral_ligament"},{"name":"Therapy","weight":0.0279596,"wikipedia_article":"http://en.wikipedia.org/wiki/Therapy"},{"name":"Trial","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Trial"},{"name":"Bright (Japanese band)","weight":0.0168623,"wikipedia_article":"http://en.wikipedia.org/wiki/Bright_(Japanese_band)"}]}
